CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Apr. 26, 2014	Apr. 27, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (825)	$ 19,581
Depreciation and amortization	16,038	15,005
Deferred taxes	(6,969)	(4,338)
Provision to value inventories at LIFO	250	300
Non-cash share-based compensation	2,442	2,422
Income from partnerships		(1,450)
Change in merchandise inventories	(3,614)	(1,392)
Change in patronage dividend receivable	2,677	2,500
Change in accounts payable to Wakefern	(16)	(2,138)
Change in accounts payable and accrued expenses	1,176	(1,228)
Change in income taxes payable	19,967	4,156
Change in other assets and liabilities	4,719	1,613
Net cash provided by operating activities	35,845	35,031
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(41,435)	(14,533)
Investment in notes receivable from Wakefern	(41,196)	(1,119)
Maturity of notes receivable from Wakefern	23,420
Proceeds from partnerships		1,980
Net cash used in investing activities	(59,211)	(13,672)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	217	1,062
Excess tax benefit related to share-based compensation	46	369
Principal payments of long-term debt	(1,204)	(1,451)
Treasury stock purchases	(2,569)
Dividends	(9,301)	(21,006)
Net cash used in financing activities	(12,811)	(21,026)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(36,177)	333
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	109,571	103,103
CASH AND CASH EQUIVALENTS, END OF PERIOD	73,394	103,436
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:
Cash payments for interest	3,189	3,010
Cash payments for income taxes	$ 5,620	$ 13,934